Constant Contract, Inc. (CTCT) Tops Q2 EPS by 3c, Guides FY In-Line
Get Alerts CTCT Hot Sheet
Join SI Premium – FREE
Constant Contract, Inc. (NASDAQ: CTCT) reported Q2 EPS of $0.22, $0.03 better than the analyst estimate of $0.19. Revenue for the quarter came in at $81.3 million versus the consensus estimate of $81.18 million.
Constant Contract, Inc. sees FY2014 EPS of $1.02, versus the consensus of $1.02. Constant Contract, Inc. sees FY2014 revenue of $331 million, versus the consensus of $330 million.
For earnings history and earnings-related data on Constant Contract, Inc. (CTCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Ovintiv Inc. (OVV) Tops Q3 EPS by 3c
- Tarsus Pharmaceuticals, Inc. (TARS) Misses Q3 EPS by 1293c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share